Q3 2016 13F Holders as of 30 Sep 2016
-
Type / Class
-
Equity / SHS USD
-
Total 13F shares
-
53,391,287
-
Share change
-
-145,336
-
Total reported value
-
$6,483,323,799
-
Put/Call ratio
-
199%
-
Price per share
-
$121.48
-
Number of holders
-
317
-
Value change
-
-$52,478,840
-
Number of buys
-
142
-
Number of sells
-
197
Institutional Holders of Jazz Pharmaceuticals plc - SHS USD (JAZZ) as of Q3 2016
As of 30 Sep 2016,
Jazz Pharmaceuticals plc - SHS USD (JAZZ) was held by
317 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
53,391,287 shares.
The largest 10 holders included
FMR LLC, PUTNAM INVESTMENTS LLC, VANGUARD GROUP INC, FIL Ltd, WESTFIELD CAPITAL MANAGEMENT CO LP, CADIAN CAPITAL MANAGEMENT, LP, Bank of New York Mellon Corp, Partner Fund Management, L.P., BlackRock Institutional Trust Company, N.A., and BlackRock Fund Advisors.
This page lists
318
institutional shareholders reporting positions in this security
for the Q3 2016 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.